Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Early Alzheimer's trials: new developments.

Vellas B, Aisen PS.

J Nutr Health Aging. 2010 Apr;14(4):293. No abstract available.

PMID:
20305997
2.

The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.

Wilcock DM.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):386-94. Review.

PMID:
20522016
3.

Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'.

Castellani RJ, Smith MA.

J Pathol. 2011 Jun;224(2):147-52. doi: 10.1002/path.2885. Review.

PMID:
21557219
4.

Can statins put the brakes on Alzheimer's disease?

Whitfield JF.

Expert Opin Investig Drugs. 2006 Dec;15(12):1479-85. Review.

PMID:
17107274
5.

APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.

Hussain I.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):395-402. Review.

PMID:
20522015
6.

Metal-protein attenuating compounds and Alzheimer's disease.

Ritchie CW, Bush AI, Masters CL.

Expert Opin Investig Drugs. 2004 Dec;13(12):1585-92. Review.

PMID:
15566316
7.

The development of new therapeutics for Alzheimer's disease.

Carter MD, Simms GA, Weaver DF.

Clin Pharmacol Ther. 2010 Oct;88(4):475-86. doi: 10.1038/clpt.2010.165. Epub 2010 Sep 1. Review.

PMID:
20811351
8.

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease.

Soto C.

Mol Med Today. 1999 Aug;5(8):343-50. Review.

PMID:
10431167
9.

Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease.

Rojas-Fernandez CH, Chen M, Fernandez HL.

Pharmacotherapy. 2002 Dec;22(12):1547-63. Review.

PMID:
12495166
10.

Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression?

Miida T, Takahashi A, Tanabe N, Ikeuchi T.

Curr Opin Lipidol. 2005 Dec;16(6):619-23. Review.

PMID:
16276238
11.

beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.

Adlard PA, James SA, Bush AI, Masters CL.

Drugs Today (Barc). 2009 Apr;45(4):293-304. doi: 10.1358/dot.2009.45.4.1353853. Review.

PMID:
19499094
12.

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.

Fisher A, Brandeis R, Haring R, Eshhar N, Heldman E, Karton Y, Eisenberg O, Meshulam H, Marciano D, Bar-Ner N, Pittel Z.

J Physiol Paris. 1998 Oct-Dec;92(5-6):337-40. Review.

PMID:
9789833
13.

Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?

Moreira PI, Smith MA, Zhu X, Honda K, Lee HG, Aliev G, Perry G.

Drug News Perspect. 2005 Jan-Feb;18(1):13-9. Review.

PMID:
15753972
14.

Tau therapeutics for Alzheimer's disease: the promise and the challenges.

Gold M.

J Mol Neurosci. 2002 Dec;19(3):331-4. Review.

PMID:
12540060
15.

Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation.

Bar-Am O, Amit T, Weinreb O, Youdim MB, Mandel S.

J Alzheimers Dis. 2010;21(2):361-71. doi: 10.3233/JAD-2010-100150. Review.

PMID:
20555137
16.

Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Parnetti L, Senin U, Mecocci P.

Drugs. 1997 May;53(5):752-68. Review.

PMID:
9129864
17.

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS.

Curr Drug Targets. 2003 Feb;4(2):97-112. Review.

PMID:
12558063
18.

[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis].

Sugimoto H.

Yakugaku Zasshi. 2010 Apr;130(4):521-6. Review. Japanese.

19.

Cholesterol, A beta and Alzheimer's disease.

Hartmann T.

Trends Neurosci. 2001 Nov;24(11 Suppl):S45-8. Review.

PMID:
11881745
20.

Recent developments in Alzheimer's disease therapeutics.

Rafii MS, Aisen PS.

BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. Review.

Items per page

Supplemental Content

Write to the Help Desk